Bacteriology and Inflammation in Bronchiectasis

NCT01761214 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Bronchiectasis

Interventions

DRUG: Fluroquinolones
DRUG: Beta-lactamase inhibitor

Sponsor

Guangzhou Institute of Respiratory Disease